Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Flaxseed combined with low-dose estrogen therapy preserves bone tissue in ovariectomized rats.

Sacco SM, Jiang JM, Reza-López S, Ma DW, Thompson LU, Ward WE.

Menopause. 2009 May-Jun;16(3):545-54. doi: 10.1097/gme.0b013e31818fc00a.

PMID:
19182694
2.

In search of an animal model for postmenopausal diseases.

Thorndike EA, Turner AS.

Front Biosci. 1998 Apr 16;3:c17-26. Review.

3.

Polyunsaturated fatty acids. Is there a role in postmenopausal osteoporosis prevention?

Albertazzi P, Coupland K.

Maturitas. 2002 May 20;42(1):13-22. Review.

PMID:
12020975
4.

Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review.

Trevisani VF, Riera R, Imoto AM, Saconato H, Atallah AN.

Sao Paulo Med J. 2008 Sep;126(5):279-84. Review.

5.

The role of phytoestrogens in the prevention and treatment of osteoporosis in ovarian hormone deficiency.

Arjmandi BH.

J Am Coll Nutr. 2001 Oct;20(5 Suppl):398S-402S; discussion 417S-420S. Review.

PMID:
11603649
6.

Tibolone and its effects on bone: a review.

Berning B, Bennink HJ, Fauser BC.

Climacteric. 2001 Jun;4(2):120-36. Review.

PMID:
11428176
7.
8.

Isoflavones and postmenopausal bone health: a viable alternative to estrogen therapy?

Scheiber MD, Rebar RW.

Menopause. 1999 Fall;6(3):233-41. Review.

PMID:
10486794
9.

Implications of dietary α-linolenic acid in bone health.

Kim Y, Ilich JZ.

Nutrition. 2011 Nov-Dec;27(11-12):1101-7. doi: 10.1016/j.nut.2011.05.012. Epub 2011 Jul 2. Review.

PMID:
21726979
10.

The ovariectomized rat model of postmenopausal bone loss.

Kalu DN.

Bone Miner. 1991 Dec;15(3):175-91. Review.

PMID:
1773131
11.

Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis.

Lewiecki EM.

Expert Opin Investig Drugs. 2007 Oct;16(10):1663-72. Review.

PMID:
17922629
12.

What can be learned from the levormeloxifene experience?

Ravn P, Nielsen TF, Christiansen C.

Acta Obstet Gynecol Scand. 2006;85(2):135-42. Review.

PMID:
16532904
13.

Flaxseed: a potential source of food, feed and fiber.

Singh KK, Mridula D, Rehal J, Barnwal P.

Crit Rev Food Sci Nutr. 2011 Mar;51(3):210-22. doi: 10.1080/10408390903537241. Review.

PMID:
21390942
14.
15.

[Animal models of post-menopausal osteoporosis].

Barlet JP, Coxam V, Davicco MJ, Gaumet N.

Reprod Nutr Dev. 1994;34(3):221-36. Review. French.

PMID:
8049016
16.

Process-induced compositional changes of flaxseed.

Wanasundara PK, Shahidi F.

Adv Exp Med Biol. 1998;434:307-25. Review.

PMID:
9598210
17.

[Selective estrogen receptor modulators in treatment of postmenopausal osteoporosis].

Meczekalski B, Czyzyk A.

Ginekol Pol. 2009 Mar;80(3):213-7. Review. Polish.

PMID:
19382614
18.

High-dose vitamin K supplementation reduces fracture incidence in postmenopausal women: a review of the literature.

Iwamoto J, Sato Y, Takeda T, Matsumoto H.

Nutr Res. 2009 Apr;29(4):221-8. doi: 10.1016/j.nutres.2009.03.012. Review.

PMID:
19410972
19.

Improvement in bone strength parameters. The role of strontium ranelate.

Tournis S.

J Musculoskelet Neuronal Interact. 2007 Jul-Sep;7(3):266-7. Review.

20.

Controlled flax interventions for the improvement of menopausal symptoms and postmenopausal bone health: a systematic review.

Dew TP, Williamson G.

Menopause. 2013 Nov;20(11):1207-15. doi: 10.1097/GME.0b013e3182896ae5. Review.

PMID:
23571524
Items per page

Supplemental Content

Write to the Help Desk